Common side effects of Sular include: headache and peripheral edema.
Other side effects include: dizziness.
See below for a comprehensive list of adverse effects.
As well as its needed effects, nisoldipine (the active ingredient contained in Sular) may cause unwanted side effects that require medical attention.
Some nisoldipine side effects may not need any medical attention.
As your body gets used to the medicine these side effects may disappear.
Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
Nisoldipine is generally well tolerated.
In controlled trials of patients with hypertension,  of treated patients discontinued therapy due to adverse drug events, compared with  of placebo patients.
The most common side effects are related to the vasodilating properties of nisoldipine (the active ingredient contained in Sular) and are dose-related.
Some patients, particularly those with severe obstructive coronary artery disease, have developed increased frequency, duration, and/or severity of angina, or acute myocardial infarction, after starting calcium channel blocker therapy or at the time of dosage increase.
In controlled studies of nisoldipine (the active ingredient contained in Sular) in patients with angina this was seen in approximately  of treated patients, compared with  of patients given placebo.
Cardiovascular side effects have included peripheral edema (up to ), vasodilation , palpitation , and chest pain .
Atrial fibrillation, cerebrovascular accident, congestive heart failure, first degree AV block, hypertension, hypotension, jugular venous distension, migraine, myocardial infarction, postural hypotension, ventricular extrasystoles, supraventricular tachycardia, syncope, systolic ejection murmur, T wave abnormalities on ECG (flattening, inversion, nonspecific changes), and venous insufficiency have been reported in less than or equal to  of patients.
Initial therapy with nisoldipine can induce unstable angina pectoris.
Nervous system side effects have included headache (up to ) and dizziness .
Abnormal dreams, abnormal thinking and confusion, amnesia, anxiety, ataxia, cerebral ischemia, decreased libido, depression, hypesthesia, hypertonia, insomnia, nervousness, paresthesia, somnolence, tremor, and vertigo have been reported in less than or equal to  of patients.
Respiratory side effects have included sinusitis (up to ) and pharyngitis (up to ).
Asthma, dyspnea, end inspiratory wheeze and fine rales, epistaxis, increased cough, laryngitis, pleural effusion, and rhinitis have been reported in less than or equal to  of patients.
Gastrointestinal side effects have included nausea  and anorexia, colitis, diarrhea, dry mouth, dyspepsia, dysphagia, flatulence, gastritis, gastrointestinal hemorrhage, gingival hyperplasia, glossitis, increased appetite, melena, mouth ulcerations, and taste disturbance in less than or equal to  of patients.
Dermatologic side effects have included rash  and acne, alopecia, dry skin, exfoliative dermatitis, fungal dermatitis, herpes simplex, herpes zoster, maculopapular rash, pruritus, pustular rash, skin discoloration, skin ulcer, sweating, and urticaria in less than or equal to  of patients.
Photosensitivity has been reported with immediate release nisoldipine (the active ingredient contained in Sular) during postmarketing experience.
Genitourinary side effects have included dysuria, hematuria, impotence, increased BUN and serum creatinine, nocturia, urinary frequency, vaginal hemorrhage, and vaginitis in less than or equal to  of patients.
Gynecomastia has been reported with the use of calcium channel blockers during postmarketing experience.
Metabolic side effects have included gout, hypokalemia, increased serum creatine kinase, increased nonprotein nitrogen, weight gain, and weight loss in less than or equal to  of patients.
Hematologic side effects have included anemia, ecchymoses, leukopenia, and petechiae in less than or equal to  of patients.
Endocrine side effects have included diabetes mellitus and thyroiditis in less than or equal to  of patients.
Hepatic side effects have included abnormal liver function tests and hepatomegaly in less than or equal to  of patients.
Hypersensitivity side effects have included systemic hypersensitivity reaction (including angioedema, shortness of breath, tachycardia, chest tightness, hypotension, and/or rash) during postmarketing experience.
Musculoskeletal side effects have included arthralgia, arthritis, leg cramps, myalgia, myasthenia, myositis, and tenosynovitis in less than or equal to  of patients.
Ocular side effects have included abnormal vision, amblyopia, blepharitis, glaucoma, itchy eyes, keratoconjunctivitis, retinal detachment, watery eyes, temporary unilateral vision loss, and vitreous floater in less than or equal to  of patients.
Other side effects have included cellulitis, chills, ear pain, facial edema, fever, flu syndrome, malaise, otitis media, and tinnitus in less than or equal to  of patients.
It is possible that some side effects of Sular may not have been reported.
These can be reported to the FDA here.
Always consult a healthcare professional for medical advice.
Bloating or swelling of face, arms, hands, lower legs, or feet
rapid weight gain
tingling of hands or feet
unusual weight gain or loss
Chest pain
dizziness, lightheadedness, or fainting
fast, irregular, pounding, or racing heartbeat or pulse
feeling of warmth or heat
flushing or redness of skin, especially on face and neck
headache
rash
sweating
Chest tightness
shortness of breath
swelling of the arms, face, legs, lips, tongue, or throat
Body aches or pain
congestion
cough
dryness or soreness of throat
fever
heartbeat sensations
hoarseness
pain or tenderness around eyes and cheekbones
runny nose
stuffy nose
tender, swollen glands in neck
trouble in swallowing
voice changes